Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5992)
All Articles published online
|
Dec 21, 2006 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Minagawa M, Makuuchi M. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol 2006; 12(47): 7561-7567 [PMID: 17171782 DOI: 10.3748/wjg.v12.i47.7561] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i47/7561.htm |
| Number | Citing Articles |
| 1 |
Ruihua Duan, Fen Gong, Yan Wang, Caixia Huang, Jiaming Wu, Leihao Hu, Min Liu, Shijun Qiu, Liming Lu, Yisheng Lin. Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis. World Journal of Surgical Oncology 2023; 21(1) doi: 10.1186/s12957-023-02961-7
|
| 2 |
Matthew Quirk, Yun Hwan Kim, Sammy Saab, Edward Wolfgang Lee. Management of hepatocellular carcinoma with portal vein thrombosis. World Journal of Gastroenterology 2015; 21(12): 3462-3471 doi: 10.3748/wjg.v21.i12.3462
|
| 3 |
Xiao‐Long Li, Wei‐Xing Guo, Xiao‐Dong Hong, Liang Yang, Kang Wang, Jie Shi, Nan Li, Meng‐Chao Wu, Shu‐Qun Cheng. Efficacy of the treatment of transarterial chemoembolization combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis. Hepatology Research 2016; 46(11): 1088 doi: 10.1111/hepr.12657
|
| 4 |
Maria Pleguezuelo, Giacomo Germani, Laura Marelli, Elias Xiruochakis, Maria Misseri, Pinelopi Manousou, Vasiliki Arvaniti, Andrew K Burroughs. Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2008; 2(6): 761 doi: 10.1586/17474124.2.6.761
|
| 5 |
Emrullah Birgin, Christoph Reissfelder, Nuh Rahbari. Remote Ischemic Preconditioning in a Cirrhotic Patient Undergoing Major Hepatectomy. Cureus 2020; doi: 10.7759/cureus.9056
|
| 6 |
Junwei Chen, Lisha Lai, Churen Zhou, Junyang Luo, Haofan Wang, Mingan Li, Mingsheng Huang. Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus. Cancer Imaging 2023; 23(1) doi: 10.1186/s40644-023-00581-8
|
| 7 |
Zili Hu, Zhenyun Yang, Jiongliang Wang, Yizhen Fu, Zhiwen Hu, Zhongguo Zhou, Minshan Chen, Yaojun Zhang. Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1223632
|
| 8 |
Su Jong Yu, Yoon Jun Kim. Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein. World Journal of Hepatology 2015; 7(11): 1553-1561 doi: 10.4254/wjh.v7.i11.1553
|
| 9 |
Yuki Nakajima, Atsushi Takahashi, Yukiko Kanno, Naohiko Gunji, Hiromichi Imaizumi, Manabu Hayashi, Ken Okai, Kazumichi Abe, Hiroshi Watanabe, Hiromasa Ohira. Paralytic Ileus due to Superior Mesenteric Venous Thrombosis after Transarterial Injection for Hepatocellular Carcinoma. Internal Medicine 2016; 55(1): 37 doi: 10.2169/internalmedicine.55.5907
|
| 10 |
Dongdong Zhou, Xiaoli Liu, Xinhui Wang, Fengna Yan, Peng Wang, Huiwen Yan, Yuyong Jiang, Zhiyun Yang. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07916-3
|
| 11 |
Takashi Kokudo, Kiyoshi Hasegawa, Yutaka Matsuyama, Tadatoshi Takayama, Namiki Izumi, Masumi Kadoya, Masatoshi Kudo, Yonson Ku, Michiie Sakamoto, Osamu Nakashima, Shuichi Kaneko, Norihiro Kokudo. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. Journal of Hepatology 2016; 65(5): 938 doi: 10.1016/j.jhep.2016.05.044
|
| 12 |
Keera Kang, Sung Kyu Song, Chul-Woon Chung, Yongkeun Park. Value of surgical resection compared to transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein tumor thrombus: A meta-analysis of hazard ratios from five observational studies. Annals of Hepato-Biliary-Pancreatic Surgery 2020; 24(3): 243 doi: 10.14701/ahbps.2020.24.3.243
|
| 13 |
Satoru Murata, Takahiko Mine, Fumie Sugihara, Daisuke Yasui, Hidenori Yamaguchi, Tatsuo Ueda, Shiro Onozawa, Shin-ichiro Kumita. Interventional treatment for unresectable hepatocellular carcinoma. World Journal of Gastroenterology 2014; 20(37): 13453-13465 doi: 10.3748/wjg.v20.i37.13453
|
| 14 |
Michihisa Moriguchi, Mitsuhiro Furuta, Yoshito Itoh. A Review of Non-operative Treatments for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombus. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2016.00075
|
| 15 |
Brian I. Carr, Vito Guerra, Edoardo G. Giannini, Fabio Farinati, Francesca Ciccarese, Gian Ludovico Rapaccini, Maria Di Marco, Luisa Benvegnù, Marco Zoli, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani. Association of Abnormal Plasma Bilirubin With Aggressive Hepatocellular Carcinoma Phenotype. Seminars in Oncology 2014; 41(2): 252 doi: 10.1053/j.seminoncol.2014.03.006
|
| 16 |
Masahiro Murakami, Shogo Kobayashi, Shigeru Marubashi, Hidetoshi Eguchi, Yutaka Takeda, Masahiro Tanemura, Hiroshi Wada, Koji Umeshita, Wakasa Kennichi, Yuichiro Doki, Masaki Mori, Hiroaki Nagano. Isolated metastasis to the gallbladder from hepatocellular carcinoma. Hepatology Research 2010; 40(8): 793 doi: 10.1111/j.1872-034X.2010.00689.x
|
| 17 |
Andrea Lan Tsai, Charles T. Burke, Andrew S. Kennedy, Dominic T. Moore, Matthew A. Mauro, Robert D. Dixon, Joseph M. Stavas, Stephen A. Bernard, Amir H. Khandani, Bert H. O'Neil. Use of Yttrium-90 Microspheres in Patients with Advanced Hepatocellular Carcinoma and Portal Vein Thrombosis. Journal of Vascular and Interventional Radiology 2010; 21(9): 1377 doi: 10.1016/j.jvir.2010.04.027
|
| 18 |
Hideki Iwamoto, Mika Nomiyama, Takashi Niizeki, Shigeo Shimose, Tomotake Shirono, Masahito Nakano, Manabu Satani, Syusuke Okamura, Yu Noda, Naoki Kamachi, Miwa Sakai, Hiroyuki Suzuki, Ryoko Kuromatsu, Etsuyo Ogo, Toshi Abe, Masatoshi Tanaka, Hironori Koga, Takuji Torimura. Dose and Location of Irradiation Determine Survival for Patients with Hepatocellular Carcinoma with Macrovascular Invasion in External Beam Radiation Therapy. Oncology 2019; 96(4): 192 doi: 10.1159/000495568
|
| 19 |
Prashant Bhangui. Liver transplantation and resection in patients with hepatocellular cancer and portal vein tumor thrombosis: Feasible and effective?. Hepatobiliary & Pancreatic Diseases International 2024; 23(2): 123 doi: 10.1016/j.hbpd.2023.10.002
|
| 20 |
Li-feng Huang, Xianglei Xing, Dong Wu, Yong Xia, Jun Li, Kui Wang, Zhen-lin Yan, Xu-ying Wan, Le-hua Shi, Tian Yang, Wan Yee Lau, Meng-chao Wu, Feng Shen. A novel scoring system predicts adjuvant chemolipiodolization benefit for hepatocellular carcinoma patients after hepatectomy. Oncotarget 2016; 7(18): 25493 doi: 10.18632/oncotarget.8333
|
| 21 |
Han Lee, Sunmin Park, Yeon Seo, Won Yoon, Chai Rim. Benefits of Local Treatment Including External Radiotherapy for Hepatocellular Carcinoma with Portal Invasion. Biology 2021; 10(4): 326 doi: 10.3390/biology10040326
|
| 22 |
Yoshiyuki Wada, Yuko Takami, Hajime Matsushima, Masaki Tateishi, Tomoki Ryu, Munehiro Yoshitomi, Taisei Matsumura, Hideki Saitsu. The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Study. Internal Medicine 2018; 57(10): 1345 doi: 10.2169/internalmedicine.9826-17
|
| 23 |
Tian-Zhu Yu, Wen Zhang, Qing-Xin Liu, Wen-Hui Li, Jing-Qin Ma, Zi-Han Zhang, Min-Jie Yang, Jian-Hua Wang, Bing Chen, Shao-Chong Zeng, Jian-Jun Luo, Ling-Xiao Liu, Zhi-Ping Yan. Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus. Oncotarget 2017; 8(7): 12108 doi: 10.18632/oncotarget.14520
|
| 24 |
Masafumi Ikeda, Seishi Maeda, Hiroshi Ashihara, Hiroyasu Nagahama, Motohiko Tanaka, Yutaka Sasaki. Transcatheter arterial infusion chemotherapy with cisplatin–lipiodol suspension in patients with hepatocellular carcinoma. Journal of Gastroenterology 2010; 45(1): 60 doi: 10.1007/s00535-009-0109-8
|
| 25 |
Ying-Fen Hong, Zhan-Hong Chen, Xiao-Kun Ma, Xing Li, Dong-Hao Wu, Jie Chen, Min Dong, Li Wei, Tian-Tian Wang, Dan-Yun Ruan, Ze-Xiao Lin, Jing-Yun Wen, Qu Lin, Chang-Chang Jia, Xiang-Yuan Wu. Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma. Tumor Biology 2016; 37(4): 5265 doi: 10.1007/s13277-015-4366-2
|
| 26 |
Stephen L Chan, Charing CN Chong, Anthony WH Chan, Darren MC Poon, Kenneth SH Chok. Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016. World Journal of Gastroenterology 2016; 22(32): 7289-7300 doi: 10.3748/wjg.v22.i32.7289
|
| 27 |
Jianghai Zhao, Hui Zhang, Lunshou Wei, Shuping Xie, Zhimin Suo. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison. Oncotarget 2017; 8(9): 15101 doi: 10.18632/oncotarget.13145
|
| 28 |
Lei Liang, Ting-Hao Chen, Chao Li, Hao Xing, Jun Han, Ming-Da Wang, Han Zhang, Wan Yee Lau, Meng-Chao Wu, Feng Shen, Tian Yang. A systematic review comparing outcomes of surgical resection and non-surgical treatments for patients with hepatocellular carcinoma and portal vein tumor thrombus. HPB 2018; 20(12): 1119 doi: 10.1016/j.hpb.2018.06.1804
|
| 29 |
Olaguoke Akinwande, Daniel Kim, Jacob Edwards, Russell Brown, Prejesh Philips, Charles Scoggins, Robert C.G. Martin. Is radioembolization (90Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis. Surgical Oncology 2015; 24(3): 270 doi: 10.1016/j.suronc.2015.06.008
|
| 30 |
Xuqi Sun, Qi Zhang, Jie Mei, Ziliang Yang, Minshan Chen, Tingbo Liang. Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09405-7
|
| 31 |
Christopher H. Crane, Eugene J. Koay. Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance. Cancer 2016; 122(13): 1974 doi: 10.1002/cncr.29878
|
| 32 |
Naoki Kawagishi. HCC with portal vein tumor thrombosis: how to manage?. Hepatology International 2020; 14(5): 609 doi: 10.1007/s12072-020-10090-6
|
| 33 |
Heather M. McGee, Michael J. King, Umut Özbek, Ashley Olson, Edward Kim, Aaron M. Fischman, Myron Schwartz, Kenneth E. Rosenzweig, Michael Buckstein. Dual Modality Radiation With External Beam Radiation Therapy and Transarterial Radioembolization for Hepatocellular Carcinoma With Gross Vascular Invasion. American Journal of Clinical Oncology 2019; 42(4): 367 doi: 10.1097/COC.0000000000000523
|
| 34 |
Shu-You Peng, Xu-An Wang, Cong-Yun Huang, Jiang-Tao Li, De-Fei Hong, Yi-Fang Wang, Bin Xu. Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus. World Journal of Gastroenterology 2018; 24(40): 4527-4535 doi: 10.3748/wjg.v24.i40.4527
|
| 35 |
Danbi Lee, Han Chu Lee, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee. Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion. Clinical and Molecular Hepatology 2018; 24(2): 144 doi: 10.3350/cmh.2017.0041
|
| 36 |
Koushiro Ohtsubo, Hiroyuki Watanabe, Tomoya Tsuchiyama, Hisatsugu Mouri, Yasushi Yamaguchi, Yoshiharu Motoo, Takashi Okai, Norio Sawabu, Junichiro Sanada, Osamu Matsui, Tokuji Kitamura, Ryusuke Fujiki, Koichi Tokuuye. Advanced hepatocellular carcinoma treated effectively with irinotecan via hepatic arterial infusion followed by proton beam therapy. Journal of Infection and Chemotherapy 2009; 15(5): 316 doi: 10.1007/s10156-009-0702-z
|
| 37 |
Aaron K T Tong, Yung Hsiang Kao, Chow Wei Too, Kenneth F W Chin, David C E Ng, Pierce K H Chow. Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry. The British Journal of Radiology 2016; 89(1062): 20150943 doi: 10.1259/bjr.20150943
|
| 38 |
Wan Yee Lau, Yee Leong Teoh, Khin Maung Win, Rheun-Chuan Lee, Vanessa H de Villa, Yun Hwan Joseph Kim, Po-Chin Liang, Ramon S Santos-Ocampo, Richard Hoau Gong Lo, Kieron Boon Leng Lim, David Wai Meng Tai, David Chee Eng Ng, Farah Gillan Irani, Apoorva Gogna, Pierce Kah-Hoe Chow. Current role of selective internal radiation with yttrium-90 in liver tumors. Future Oncology 2016; 12(9): 1193 doi: 10.2217/fon-2016-0035
|
| 39 |
Yusuke Yamamoto, Hisashi Ikoma, Ryo Morimura, Katsutoshi Shoda, Hirotaka Konishi, Yasutoshi Murayama, Shuhei Komatsu, Atsushi Shiozaki, Yoshiaki Kuriu, Takeshi Kubota, Masayoshi Nakanishi, Daisuke Ichikawa, Hitoshi Fujiwara, Kazuma Okamoto, Chouhei Sakakura, Toshiya Ochiai, Eigo Otsuji. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis. World Journal of Gastroenterology 2015; 21(1): 246-253 doi: 10.3748/wjg.v21.i1.246
|
| 40 |
M.-P. Vullierme, V. Paradis, M. Chirica, D. Castaing, J. Belghiti, O. Soubrane, J.-C. Barbare, O. Farges. Hepatocellular carcinoma – what's new?. Journal of Visceral Surgery 2010; 147(1): e1 doi: 10.1016/j.jviscsurg.2010.02.003
|
| 41 |
Tian-Tian Wu, Hu-Cheng Li, Fang Zheng, Guo-Kun Ao, Hu Lin, Wei-Min Li. Percutaneous Endovascular Radiofrequency Ablation for Malignant Portal Obstruction: An Initial Clinical Experience. CardioVascular and Interventional Radiology 2016; 39(7): 994 doi: 10.1007/s00270-016-1317-2
|
| 42 |
Onofrio A. Catalano, Garry Choy, Andrew Zhu, Peter F. Hahn, Dushyant V. Sahani. Differentiation of Malignant Thrombus from Bland Thrombus of the Portal Vein in Patients with Hepatocellular Carcinoma: Application of Diffusion-weighted MR Imaging. Radiology 2010; 254(1): 154 doi: 10.1148/radiol.09090304
|
| 43 |
Wei Cao, Jing Li, Zhi-Qun Wu, Chang-Xi Zhou, Xi Liu, Yi Wan, Yun-You Duan. Changes in Hepatic Blood Flow During Transcatheter Arterial Infusion with Heated Saline in Hepatic VX2 Tumor. CardioVascular and Interventional Radiology 2013; 36(3): 764 doi: 10.1007/s00270-012-0459-0
|
| 44 |
Rongfeng Zhang, Huishu Guo, Jingchao Xu, Bing Li, Yue-Jian Liu, Cheng Cheng, Chunyan Zhou, Yongfu Zhao, Yang Liu. Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding. Oncotarget 2016; 7(37): 60609 doi: 10.18632/oncotarget.11300
|
| 45 |
Giovanni Battista Levi Sandri. Portal Vein Thrombosis. 2021; : 157 doi: 10.1007/978-981-33-6538-4_11
|
| 46 |
Kangshun Zhu, Junwei Chen, Lisha Lai, Xiaochun Meng, Bin Zhou, Wensou Huang, Mingyue Cai, Hong Shan. Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Treatment with Transarterial Chemoembolization Combined with Sorafenib—A Retrospective Controlled Study. Radiology 2014; 272(1): 284 doi: 10.1148/radiol.14131946
|
| 47 |
Daizo Fukushima, Shigeki Imai, Noriyuki Nishino, Kohichi Hamada, Yoshinori Horikawa, Yoshiki Shiwa, Shinya Nishida, Ryota Koyanagi, Hitoshi Wada, Hideo Sakuma. A case of complete remission of advanced hepatocellular carcinoma with type III portal vein tumor thrombosis treated using transarterial chemoembolization with microspheres and radiation therapy. Clinical Journal of Gastroenterology 2020; 13(5): 847 doi: 10.1007/s12328-020-01124-5
|
| 48 |
Kotaro Matsunaga, Chiaki Okuse, Sarika Nakamura, Keigo Suetani, Shinya Ishigooka, Fumio Itoh, Michihiro Suzuki. Advanced Hepatocellular Carcinoma with Portal Vein Main Trunk Tumor Thrombosis Successfully Treated by Repeated Hepatic Arterial Cisplatin Infusion Chemotherapy. Journal of St. Marianna University 2021; 12(1): 35 doi: 10.17264/stmarieng.12.35
|
| 49 |
Seung Gyu Park, Jin Hee Kim, Sang Jun Byun, Ok Bae Kim, Jae Seok Hwang, Young Kee Oh, Tae Jin Choi. Radiation Therapy for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. The Journal of the Korean Society for Therapeutic Radiology and Oncology 2011; 29(1): 36 doi: 10.3857/jkstro.2011.29.1.36
|
| 50 |
Imam Waked, Sarah Berhane, Hidenori Toyoda, Stephen L Chan, Nicholas Stern, Daniel Palmer, Toshifumi Tada, Winnie Yeo, Frankie Mo, Dominik Bettinger, Martha M Kirstein, Mercedes Iñarrairaegui, Asmaa Gomaa, Arndt Vogel, Tim Meyer, Bruno Sangro, Paul Lai, Takashi Kumada, Philip J Johnson. Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion. British Journal of Cancer 2017; 116(4): 448 doi: 10.1038/bjc.2016.423
|
| 51 |
Toshihiro Kawai, Yoko Yashima, Takafumi Sugimoto, Takahisa Sato, Miho Kanda, Nobuyuki Enomoto, Shinpei Sato, Shuntaro Obi. Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0802-z
|
| 52 |
Jingwen Zou, Weiliang Zhu, Hui Meng, Peng Luo, Jian Zhang. Efficacy and safety of selective internal radiotherapy versus sorafenib for intermediate-locally advanced hepatocellular carcinoma: a systematic review and meta-analysis. Expert Review of Gastroenterology & Hepatology 2019; 13(3): 271 doi: 10.1080/17474124.2019.1570135
|
| 53 |
M. Kondo, M. Morimoto, K. Numata, A. Nozaki, K. Tanaka. Hepatic Arterial Infusion Therapy with a Fine Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Japanese Journal of Clinical Oncology 2011; 41(1): 69 doi: 10.1093/jjco/hyq145
|
| 54 |
Rumi Matono, Shohei Yoshiya, Takashi Motomura, Takeo Toshima, Hiroto Kayashima, Toshiro Masuda, Tomoharu Yoshizumi, Akinobu Taketomi, Ken Shirabe, Yoshihiko Maehara. Factors linked to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical resection. HPB 2012; 14(4): 247 doi: 10.1111/j.1477-2574.2011.00436.x
|
| 55 |
Yong Gil Kim, Jong Ryul Eun, Tae Nyeun Kim, Heon Ju Lee, Jae Woon Kim, Jay Chun Chang, Sung Su Yun, Joon Hyuk Choi. Pathological Complete Remission of Advanced Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis by Hepatic Arterial Infusion Chemotherapy. Gut and Liver 2010; 4(2): 266 doi: 10.5009/gnl.2010.4.2.266
|
| 56 |
Yeonjung Ha, Seungbong Han, Ju Hyun Shim, Gi-Young Ko, Hyun-Ki Yoon, Kyu-Bo Sung, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Han Chu Lee. Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2015; 26(8): 1093 doi: 10.1016/j.jvir.2015.04.010
|
| 57 |
Pietro E. Majno, Gilles Mentha, Vincenzo Mazzaferro. Partial hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: Confirming the trial that will never be, and some comments on the indications for liver resection. Hepatology 2010; 51(4): 1116 doi: 10.1002/hep.23648
|
| 58 |
Guiliang Wang, Yan Liu, Shu-feng Zhou, Ping Qiu, Linfang Xu, Ping Wen, Jianbo Wen, Xianzhong Xiao. Sorafenib combined with transarterial chemoembolization in patients with hepatocellular carcinoma: a meta-analysis and systematic review. Hepatology International 2016; 10(3): 501 doi: 10.1007/s12072-015-9700-7
|
| 59 |
Hongyuan Liang, Peng Cui, Qiyong Guo, Xiaonan Mao, Feng Wen, Wei Sun, Ming Shan, Zaiming Lu. Prognostic factors of hepatocellular carcinoma patients with portal vein tumor thrombosis treated with transcatheter arterial chemoembolization. Asia-Pacific Journal of Clinical Oncology 2017; 13(5) doi: 10.1111/ajco.12606
|
| 60 |
J.-s. Zheng, J. Long, B. Sun, N.-n. Lu, D. Fang, L.-y. Zhao, N. Du. Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: Extending the indication for ablation?. Clinical Radiology 2014; 69(6): e253 doi: 10.1016/j.crad.2014.01.015
|
| 61 |
Hai-Hong Ye, Jia-Zhou Ye, Zhi-Bo Xie, Yu-Chong Peng, Jie Chen, Liang Ma, Tao Bai, Jun-Ze Chen, Zhan Lu, Hong-Gui Qin, Bang-De Xiang, Le-Qun Li. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein. World Journal of Gastroenterology 2016; 22(13): 3632-3643 doi: 10.3748/wjg.v22.i13.3632
|
| 62 |
Anil Chauhan, Naveen Garg, Christine O. Menias, Catherine E. Devine, Priya R. Bhosale, Aparna Balachandran. Tumor Thrombus as a Rare Presentation of Lymphoma: A Case Series of 14 Patients. American Journal of Roentgenology 2015; 204(4): W398 doi: 10.2214/AJR.14.12782
|
| 63 |
Meng-Chuan Lu, Wen-Yen Huang, Hsiu-Lung Fan, Teng-Wei Chen, Wei-Chou Chang, Hsuan-Hwai Lin, Yu-Lueng Shih, Tsai-Yuan Hsieh, Wei-Chen Huang. Beneficial Effect of Combining Radiotherapy and Transarterial Chemoembolization on Patient Survival in Hepatocellular Carcinomas and Macrovascular Invasion Treated with Sorafenib. Cancers 2023; 15(10): 2687 doi: 10.3390/cancers15102687
|
| 64 |
Li Zhou, Jing-An Rui, Shao-Bin Wang, Shu-Guang Chen, Qiang Qu. Clinicopathological Predictors of Poor Survival and Recurrence After Curative Resection in Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis. Pathology & Oncology Research 2015; 21(1): 131 doi: 10.1007/s12253-014-9798-2
|
| 65 |
Xiang-quan Kong, Ya-ping Dong, Jun-xin Wu, Jun-yan He, Yu-yin Le, Kai-xin Du, Qing-qin Peng, Jin-luan Li. High-biologically effective dose palliative radiotherapy for a tumor thrombus might improve the long-term prognosis of hepatocellular carcinoma: a retrospective study. Radiation Oncology 2017; 12(1) doi: 10.1186/s13014-017-0831-y
|
| 66 |
Takashi Kokudo, Kiyoshi Hasegawa, Satoshi Yamamoto, Junichi Shindoh, Nobuyuki Takemura, Taku Aoki, Yoshihiro Sakamoto, Masatoshi Makuuchi, Yasuhiko Sugawara, Norihiro Kokudo. Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis. Journal of Hepatology 2014; 61(3): 583 doi: 10.1016/j.jhep.2014.04.032
|
| 67 |
Zhi-qiang Cai, Shu-bin Si, Chen Chen, Yaling Zhao, Yong-yi Ma, Lin Wang, Zhi-min Geng, Ferruccio Bonino. Analysis of Prognostic Factors for Survival after Hepatectomy for Hepatocellular Carcinoma Based on a Bayesian Network. PLOS ONE 2015; 10(3): e0120805 doi: 10.1371/journal.pone.0120805
|
| 68 |
Jian-Hai Guo, Shao-Xing Liu, Song Gao, Fu-Xin Kou, Xin Zhang, Di Wu, Xiao-Ting Li, Hui Chen, Xiao-Dong Wang, Peng Liu, Peng-Jun Zhang, Hai-Feng Xu, Guang Cao, Lin-Zhong Zhu, Ren-Jie Yang, Xu Zhu. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(27): 3975-3988 doi: 10.3748/wjg.v26.i27.3975
|
| 69 |
Li Shaohua, Wang Qiaoxuan, Sun Peng, Li Qing, Yang Zhongyuan, Shi Ming, Wei Wei, Guo Rongping, Yitao Ding. Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis. PLOS ONE 2015; 10(6): e0130021 doi: 10.1371/journal.pone.0130021
|
| 70 |
Chai Hong Rim, Chul Yong Kim, Dae Sik Yang, Won Sup Yoon. Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: A meta-analysis and systematic review. Radiotherapy and Oncology 2018; 129(1): 112 doi: 10.1016/j.radonc.2017.11.013
|
| 71 |
T. Pan, X.-S. Li, Q.-K. Xie, J.-P. Wang, W. Li, P.-H. Wu, M. Zhao. Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus. Clinical Radiology 2014; 69(12): e553 doi: 10.1016/j.crad.2014.09.007
|
| 72 |
Jing-Song Chen, Qian Wang, Xi-Lin Chen, Xiao-Hui Huang, Li-Jian Liang, Jian Lei, Jiong-Qiang Huang, Dong-Ming Li, Zhi-Xiang Cheng. Clinicopathologic Characteristics and Surgical Outcomes of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Journal of Surgical Research 2012; 175(2): 243 doi: 10.1016/j.jss.2011.03.072
|
| 73 |
Qi Yao, Hongsen Zhang, Bin Xiong, Chuansheng Zheng. Combination of sorafenib and TACE inhibits portal vein invasion for intermediate stage HCC: a single center retrospective controlled study. Oncotarget 2017; 8(45): 79012 doi: 10.18632/oncotarget.20745
|
| 74 |
Shreya Shalimar Datta Gupta, Shamim A. Shamim, Shivanand Gamanagatti, Priyanka Gupta, Maroof A. Khan, Madhav B. Mallia, Viju Chirayil, Ashutosh Dash, Chandrasekhar Bal. Re-188 lipiodol in hepatocellular carcinoma with portal vein thrombosis: a pilot study using novel chelating agent N-DEDC and its comparison with (A)HDD. Nuclear Medicine Communications 2024; doi: 10.1097/MNM.0000000000001840
|
| 75 |
Xinwei Yang, Zhiquan Qiu, Rongzhen Ran, Longjiu Cui, Xiangji Luo, Mengchao Wu, Wei‑Feng Tan, Xiaoqing Jiang. Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis. Oncology Letters 2018; doi: 10.3892/ol.2018.9108
|
| 76 |
Hee Mang Yoon, Jin Hyoung Kim, Eun-Joung Kim, Dong Il Gwon, Gi-Young Ko, Heung Kyu Ko. Modified Cisplatin-based Transcatheter Arterial Chemoembolization for Large Hepatocellular Carcinoma: Multivariate Analysis of Predictive Factors for Tumor Response and Survival in a 163-Patient Cohort. Journal of Vascular and Interventional Radiology 2013; 24(11): 1639 doi: 10.1016/j.jvir.2013.06.017
|
| 77 |
Antonio Giorgio, Antonella Di Sarno, Giorgio de Stefano, Nunzia Farella, Umberto Scognamiglio, Manuela de Stefano, Valentina Giorgio. Hepatocellular Carcinoma With Cirrhosis: Are Patients With Neoplastic Main Portal Vein Invasion Eligible for Percutaneous Radiofrequency Ablation of Both the Nodule and the Portal Venous Tumor Thrombus?. American Journal of Roentgenology 2009; 193(4): 948 doi: 10.2214/AJR.08.2087
|
| 78 |
Jian-Jun Luo, Zi-Han Zhang, Qing-Xin Liu, Wen Zhang, Jian-Hua Wang, Zhi-Ping Yan. Endovascular brachytherapy combined with stent placement and TACE for treatment of HCC with main portal vein tumor thrombus. Hepatology International 2016; 10(1): 185 doi: 10.1007/s12072-015-9663-8
|
| 79 |
Kazuhiko Sakamoto, Hiroaki Nagano. Surgical treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus. Hepatology Research 2017; 47(10): 957 doi: 10.1111/hepr.12923
|
| 80 |
Arnab Basu, Alok A. Khorana. Textbook of Gastrointestinal Oncology. 2019; : 367 doi: 10.1007/978-3-030-18890-0_21
|
| 81 |
Wansheng Wang, Jian Shen, Chen Wang, Baosheng Ren, Xiaoli Zhu, Caifang Ni. Safety and Feasibility of Helical I-125 Seed Implants Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinomas with Main Portal Vein Tumor Thrombus. CardioVascular and Interventional Radiology 2019; 42(10): 1420 doi: 10.1007/s00270-019-02256-z
|
| 82 |
Yu-Jie Huang, Hsuan-Chih Hsu, Chang-Yu Wang, Chong-Jong Wang, Hui-Chun Chen, Eng-Yen Huang, Fu-Min Fang, Sheng-Nan Lu. The Treatment Responses in Cases of Radiation Therapy to Portal Vein Thrombosis in Advanced Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2009; 73(4): 1155 doi: 10.1016/j.ijrobp.2008.06.1486
|
| 83 |
Sirish A. Kishore, Raazi Bajwa, David C. Madoff. Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update. Cancers 2020; 12(4): 791 doi: 10.3390/cancers12040791
|
| 84 |
Jia-Yan Ni, Hong-Liang Sun, Yao-Ting Chen, Jiang-Hong Luo, Dong Chen, Xiong-Ying Jiang, Lin-Feng Xu. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma. World Journal of Gastroenterology 2014; 20(46): 17483-17490 doi: 10.3748/wjg.v20.i46.17483
|
| 85 |
Young Eun Ahn, Sang Jun Suh, Hyung Joon Yim, Yeon Seok Seo, Eileen L. Yoon, Tae Hyung Kim, Young Sun Lee, Sun Young Yim, Hae Rim Kim, Seong Hee Kang, Young Kul Jung, Ji Hoon Kim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun. Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Gut and Liver 2021; 15(2): 284 doi: 10.5009/gnl19367
|
| 86 |
Mi Yean Yang, Soung Won Jeong, Dong Kyun Kim, Sang Gyune Kim, Jae Young Jang, Young Seok Kim, Joon Seong Lee, Boo Sung Kim, Jung Hoon Kim†, Yong Jae Kim†. Treatment of Hepatocellular Carcinoma with Portal Vein Thrombosis by Sorafenib Combined with Hepatic Arterial Infusion Chemotherapy. Gut and Liver 2010; 4(3): 423 doi: 10.5009/gnl.2010.4.3.423
|
| 87 |
Terrence C.H. Hui, Uei Pua. Arterial Portography during Transarterial Chemoembolization: Still a Necessity in the Age of Contrast-enhanced Cross-sectional Imaging?. Journal of Vascular and Interventional Radiology 2014; 25(1): 41 doi: 10.1016/j.jvir.2013.10.014
|
| 88 |
Ashley L. Titan, Kelly Devereaux, John D. Louie, George A. Poultsides. Clinical Trigonometry: Right Hepatic Trisegmentectomy After Radiation Trisegmentectomy for Hepatocellular Carcinoma. Digestive Diseases and Sciences 2018; 63(6): 1419 doi: 10.1007/s10620-017-4797-2
|
| 89 |
Sung Won Lee, Hae Lim Lee, Nam Ik Han, Jung Hyun Kwon, Soon Woo Nam, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon. Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil versus transarterial chemoembolization using doxorubicin for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective analysis. Therapeutic Advances in Medical Oncology 2017; 9(10): 615 doi: 10.1177/1758834017728018
|
| 90 |
Gui-Qian Huang, Ji-Na Zheng, Tian-Tian Zou, Yi-Ran Chen, Ke-Qing Shi, Sven Van Poucke, Zhang Cheng, Lu-Yi Ruan, Ming-Hua Zheng. Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2016.00035
|
| 91 |
Yadi Liao, Yun Zheng, Wei He, Qijiong Li, Jingxian Shen, Jian Hong, Ruhai Zou, Jiliang Qiu, Binkui Li, Yunfei Yuan. Sorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence. Oncology Letters 2017; 13(2): 984 doi: 10.3892/ol.2016.5525
|
| 92 |
Andrew Y. Lee, Tianming Wu, Michael W. Vannier, Giuliano Testa, Stanley L. Liauw. Unresectable Hepatocellular Carcinoma Due to Portal Venous Thrombosis: Focal Stereotactic Body Radiation Therapy Can Promote Resectability. Journal of Gastrointestinal Cancer 2012; 43(S1): 202 doi: 10.1007/s12029-012-9387-0
|
| 93 |
Fabio Piscaglia, Alice Gianstefani, Matteo Ravaioli, Rita Golfieri, Alberta Cappelli, Emanuela Giampalma, Elisabetta Sagrini, Grazia Imbriaco, Antonio Daniele Pinna, Luigi Bolondi. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. Liver Transplantation 2010; 16(5): 658 doi: 10.1002/lt.22044
|
| 94 |
Haichen Lv, Ruopeng Tan, Jiawei Liao, Zhujing Hao, Xiaolei Yang, Yang Liu, Yunlong Xia. Doxorubicin contributes to thrombus formation and vascular injury by interfering with platelet function. American Journal of Physiology-Heart and Circulatory Physiology 2020; 319(1): H133 doi: 10.1152/ajpheart.00456.2019
|
| 95 |
Qing‐he Tang, Ai‐jun Li, Guang‐ming Yang, Eric C.H. Lai, Wei‐ping Zhou, Zhi‐hao Jiang, Wan Yee Lau, Meng‐chao Wu. Surgical Resection Versus Conformal Radiotherapy Combined With TACE for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Comparative Study. World Journal of Surgery 2013; 37(6): 1362 doi: 10.1007/s00268-013-1969-x
|
| 96 |
Mineto Ohta, Chikashi Nakanishi, Naoki Kawagishi, Yasuyuki Hara, Kai Maida, Toshiaki Kashiwadate, Koji Miyazawa, Satoru Yoshida, Shigehito Miyagi, Yukihiro Hayatsu, Shunsuke Kawamoto, Yasushi Matsuda, Yoshinori Okada, Yoshikatsu Saiki, Noriaki Ohuchi. Surgical resection of recurrent extrahepatic hepatocellular carcinoma with tumor thrombus extending into the right atrium under cardiopulmonary bypass: a case report and review of the literature. Surgical Case Reports 2016; 2(1) doi: 10.1186/s40792-016-0241-7
|
| 97 |
Xiaotong Qiu, Jianye Cai, Haitian Chen, Jia Yao, Cuicui Xiao, Rong Li, Jiaqi Xiao, Jiebin Zhang, Xin Sui, Tongyu Lu, Jun Zheng, Yingcai Zhang, Yang Yang. Chemotherapy combined with radiotherapy can benefit more unresectable HCC patients with portal and/or hepatic vein invasion: a retrospective analysis of the SEER database. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1098686
|
| 98 |
Tan Tan, Yudong Xiao, Shunke Zhou, Cong Ma, Zishu Zhang. Y-configuration stent combined with iodine-125 seeds strand for the treatment of hepatocellular carcinoma with tumor thrombosis in portal vein branches. Medicine 2017; 96(46): e8660 doi: 10.1097/MD.0000000000008660
|
| 99 |
Yoshiro Matsuo, Kenji Yoshida, Hideki Nishimura, Yasuo Ejima, Daisuke Miyawaki, Haruka Uezono, Takeaki Ishihara, Hiroshi Mayahara, Takumi Fukumoto, Yonson Ku, Masato Yamaguchi, Koji Sugimoto, Ryohei Sasaki. Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy. Journal of Radiation Research 2016; 57(5): 512 doi: 10.1093/jrr/rrw028
|
| 100 |
Houbin Sun, Minghui Zhang, Ruibao Liu, Yan Liu, Yingwen Hou, Changjun Wu. Endovascular implantation of 125I seed combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma. Future Oncology 2018; 14(12): 1165 doi: 10.2217/fon-2017-0354
|
| 101 |
Tao Li, Yuanzi Yu, Juan Liu, Xiangguo Tian, Meng Kong, Lei Wu, Shaocan Tang, Shengqing Gu, Jingfang Zhao, Yi Cui, Jinhua Hu. PIVKA-II level is correlated to development of portal vein tumor thrombus in patients with HBV-related hepatocellular carcinoma. Infectious Agents and Cancer 2019; 14(1) doi: 10.1186/s13027-019-0229-6
|
| 102 |
Amber R. Matuzak. Sonography of Portal Vein Tumor Thrombus Associated With HCC. Journal of Diagnostic Medical Sonography 2013; 29(1): 44 doi: 10.1177/8756479312471898
|
| 103 |
M.-P. Vullierme, V. Paradis, M. Chirica, D. Castaing, J. Belghiti, O. Soubrane, J.-C. Barbare, O. Farges. Quoi de neuf dans la prise en charge du carcinome hépatocellulaire sur cirrhose ?. Journal de Chirurgie Viscérale 2010; 147(1): 3 doi: 10.1016/j.jchir.2009.06.009
|
| 104 |
Ahmed Shehta, Ahmed Farouk, Ahmed Nabieh Elghawalby, Mohamed Elshobary, Ahmed Aboelenin, Amgad Fouad, Mahmoud Abdelwahab Ali. Outcomes of Hepatic Resection for Hepatocellular Carcinoma Associated with Portal Vein Invasion. Journal of Surgical Research 2021; 266: 269 doi: 10.1016/j.jss.2021.04.011
|
| 105 |
Takahide Nakazawa, Hisashi Hidaka, Akitaka Shibuya, Yusuke Okuwaki, Yoshiaki Tanaka, Juichi Takada, Tsutomu Minamino, Masaaki Watanabe, Shigehiro Kokubu, Wasaburo Koizumi. Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-84
|
| 106 |
Takako Nomura, Joji Tani, Akihiro Deguchi, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Teppei Sakamoto, Asahiro Morishita, Hirohito Yoneyama, Hideki Kobara, Takayuki Sanomura, Yoshihiro Nishiyama, Keiichi Okano, Yasuyuki Suzuki, Shigeo Takahashi, Toru Shibata, Kunihiko Tsutsui, Takashi Himoto, Tsutomu Masaki. Efficacy of combined modality therapy with sorafenib following hepatic arterial injection chemotherapy and three‑dimensional conformal radiotherapy for advanced hepatocellular carcinoma with major vascular invasion. Molecular and Clinical Oncology 2019; doi: 10.3892/mco.2019.1920
|
| 107 |
Takashi Kokudo, Kiyoshi Hasegawa, Norihiro Kokudo, Takashi Kokudo, Emilie Uldry, Nicolas Demartines, Nermin Halkic. Hepatocellular Carcinoma. Annals of Surgery 2018; 267(2): e27 doi: 10.1097/SLA.0000000000001960
|
| 108 |
Chen Wang, Wansheng Wang, Jian Shen, Baosheng Ren, Xiaoli Zhu, Caifang Ni. Feasibility of Helical I-125 Seed Implant in the Portal Vein. CardioVascular and Interventional Radiology 2019; 42(1): 121 doi: 10.1007/s00270-018-2059-0
|
| 109 |
Chung Hwan Jun, Jae Hyun Yoon, Eunae Cho, Sang Soo Shin, Sung Bum Cho, Hee Joon Kim, Chang Hwan Park, Hyun Soon Kim, Sung Kyu Choi, Jong Sun Rew. Barcelona clinic liver cancer-stage C hepatocellular carcinoma. Medicine 2017; 96(17): e6745 doi: 10.1097/MD.0000000000006745
|
| 110 |
Ninggang Zheng, Xiaodong Wei, Dongzhi Zhang, Wenxiao Chai, Ming Che, Jiangye Wang, Binbin Du. Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus. Medicine 2016; 95(26): e3959 doi: 10.1097/MD.0000000000003959
|
| 111 |
Charlotte E. Costentin, Thomas Decaens, Alexis Laurent, Jean‐Charles Nault, Bernard Paule, Christian Letoublon, Alain Luciani, Julien Calderaro, René Adam, Ivan Bricault, Giuliana Amaddeo, Daniel Cherqui, Ariane Mallat, Didier Samuel, Christophe Duvoux, Nathalie Ganne‐Carrié, Françoise Roudot‐Thoraval, Eric Vibert. Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis. Liver International 2017; 37(12): 1869 doi: 10.1111/liv.13491
|
| 112 |
Sascha Kaufmann, Maximilian Schulze, Daniel Spira, Marius Horger. Modern multimodality diagnosis of portal vein infiltration in hepatocellular carcinoma and expected changes during current therapies. Acta Radiologica 2015; 56(11): 1283 doi: 10.1177/0284185114556305
|
| 113 |
Yang Liu, Xianqiang Wang, Kai Jiang, Wenzhi Zhang, Jiahong Dong. The Diagnostic Value of Tumor Biomarkers for Detecting Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombosis. Cell Biochemistry and Biophysics 2014; 69(3): 455 doi: 10.1007/s12013-014-9817-7
|
| 114 |
Po-Hong Liu, Yun-Hsuan Lee, Cheng-Yuan Hsia, Chia-Yang Hsu, Yi-Hsiang Huang, Yi-You Chiou, Han-Chieh Lin, Teh-Ia Huo. Surgical Resection Versus Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis. Annals of Surgical Oncology 2014; 21(6): 1825 doi: 10.1245/s10434-014-3510-3
|
| 115 |
Emma B. Holliday, Randa Tao, Zachary Brownlee, Prajnan Das, Sunil Krishnan, Cullen Taniguchi, Bruce D. Minsky, Joseph M. Herman, Ahmed Kaseb, Kanwal Raghav, Claudius Conrad, Jean-Nicholas Vauthey, Thomas A. Aloia, Yun Shin Chun, Christopher H. Crane, Eugene J. Koay. Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus. Clinical and Translational Radiation Oncology 2017; 4: 39 doi: 10.1016/j.ctro.2017.04.003
|
| 116 |
Yu-Chao Wang, Jin-Chiao Lee, Tsung-Han Wu, Chih-Hsien Cheng, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan, Wei-Chen Lee. Improving outcomes of liver resection for hepatocellular carcinoma associated with portal vein tumor thrombosis over the evolving eras of treatment. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02425-w
|
| 117 |
Sunil Krishnan, Laura A. Dawson, Jinsil Seong, Yasuyuki Akine, Sam Beddar, Tina M. Briere, Christopher H. Crane, Francoise Mornex. Radiotherapy for Hepatocellular Carcinoma: An Overview. Annals of Surgical Oncology 2008; 15(4): 1015 doi: 10.1245/s10434-007-9729-5
|
| 118 |
Yuanqi Wang, Jingxian Shen, Shiting Feng, Ruiming Liang, Jiaming Lai, Dongming Li, Baogang Peng, Zaiguo Wang, Cheng Huang, Ming Kuang. Hepatic resection versus transarterial chemoembolization in infiltrative hepatocellular carcinoma: A multicenter study. Journal of Gastroenterology and Hepatology 2020; 35(12): 2220 doi: 10.1111/jgh.15060
|
| 119 |
Ming-Feng Li, Huei-Lung Liang, Chia-Ling Chiang, Wei-Lun Tsai, Wen-Chi Chen, Cheng-Chung Tsai, I-Shu Chen. New Regimen of Combining Hepatic Arterial Infusion Chemotherapy and Lipiodol Embolization in Treating Hepatocellular Carcinoma with Main Portal Vein Invasion. Journal of Personalized Medicine 2022; 13(1): 88 doi: 10.3390/jpm13010088
|
| 120 |
Ji Soo Lee, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh. Long-Term Outcomes of Liver Transplantation in Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Comparison with Portal Vein Tumor Thrombus. Cancers 2023; 15(17): 4225 doi: 10.3390/cancers15174225
|
| 121 |
Sang Jin Kim, Jong Man Kim. Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis. Journal of Liver Cancer 2021; 21(2): 105 doi: 10.17998/jlc.2021.03.17
|
| 122 |
Yao Liu, Yuxin Li, Fangyuan Gao, Qun Zhang, Xue Yang, Bingbing Zhu, Shuaishuai Niu, Yunyi Huang, Ying Hu, Wei Li, Xianbo Wang. Comparison of Transcatheter Arterial Chemoembolization-Radiofrequency Ablation and Transcatheter Arterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma with Macrovascular Invasion Using Propensity Score Analysis: A Retrospective Cohort Study. Journal of Oncology 2020; 2020: 1 doi: 10.1155/2020/1341863
|
| 123 |
Kang Wang, Wei Xing Guo, Min Shan Chen, Yi Lei Mao, Bei Cheng Sun, Jie Shi, Yao Jun Zhang, Yan Meng, Ye Fa Yang, Wen Ming Cong, Meng Chao Wu, Wan Yee Lau, Shu Qun Cheng. Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus. Medicine 2016; 95(11): e3015 doi: 10.1097/MD.0000000000003015
|
| 124 |
Yuting Zhao, Xianggao Zhu, Hongzhi Wang, Dezuo Dong, Song Gao, Xu Zhu, Weihu Wang. Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined With Sorafenib in Hepatocellular Carcinoma Showing Macrovascular Invasion. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01065
|
| 125 |
Khangembam Bangkim Chandra, Abhinav Singhal. Predictors of Macrovascular Invasion and Extrahepatic Metastasis in Treatment Naive Hepatocellular Carcinoma: When Is [18F] FDG PET/CT Relevant?. Nuclear Medicine and Molecular Imaging 2021; 55(6): 293 doi: 10.1007/s13139-021-00714-6
|
| 126 |
S. Arsalan Raza, Hyun-Jung Jang, Tae Kyoung Kim. Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasound. Abdominal Imaging 2014; 39(1): 153 doi: 10.1007/s00261-013-0034-4
|
| 127 |
Prashant Bhangui. Liver transplantation and portal vein tumour thrombus: futile enterprise?. Current Opinion in Organ Transplantation 2022; 27(4): 312 doi: 10.1097/MOT.0000000000000997
|
| 128 |
Michael I. Lock, Morten Hoyer, Sean A. Bydder, Paul Okunieff, Carol A. Hahn, Anushree Vichare, Laura A. Dawson. An international survey on liver metastases radiotherapy. Acta Oncologica 2012; 51(5): 568 doi: 10.3109/0284186X.2012.681700
|
| 129 |
Matteo Serenari, Alberta Cappelli, Alessandro Cucchetti, Cristina Mosconi, Lidia Strigari, Fabio Monari, Matteo Ravaioli, Elisa Lodi Rizzini, Stefano Fanti, Rita Golfieri, Matteo Cescon. Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot Study. Liver Transplantation 2021; 27(12): 1758 doi: 10.1002/lt.26257
|
| 130 |
Sheng-Nan Lu, Jing-Houng Wang, Chien-Wei Su, Tsang-En Wang, Chia-Yen Dai, Chien-Hung Chen, Ran-Chou Chen, Sien-Sing Yang, Chien-Fu Hung, Shiu-Feng Huang, Li-Ying Liao, Jing-Houng Wang, Sheng-Nan Lu, Chien-Hung Chen, The-Ia Huo, Cheng-Chung Wu, Po-Huang Lee, Chin-Tsung Ting, Wei-Chen Lee, Gar-Yang Chau, Chien-Fu Hung, Chih-Chi Wang, King-The Lee, Jing-Houng Wang, Yi-Hsiang Huang, Chien-Wei Su, Ming-Chih Ho, Shi-Ming Lin, Guan-Tarn Huang, Kuan-Yang Chen, Tsang-En Wang, Xi-Zhang Lin, Li-Ying Liao, Jing-Houng Wang, Jen-I. Hwang, Gar-Yang Chau, Yi-You Chiou, Chung-Kwe Wang, Jui-Ting Hu, Sheng-Nan Lu, Shinn-Cherng Chen, Jen-I. Hwang, Po-Chin Liang, Chien-Fu Hung, Rheun-Chuan Lee, Ding-Kwo Wu, Cheng-Yao Lin, Chen-Chun Lin, Ran-Chou Chen, Ann-Lii Cheng, Chiun Hsu, Yi-Hsiang Huang, Yee Chao, Li-Tzong Chen, Po-Ming Wang, Po-Ming Wang, Ji-Hong Hong, Hsuan-Chih Hsu, Shang-Wen Chen, Stephen Wan Leung, Jason Chia-Hsien Cheng, Chen-Chun Lin, Chien-Fu Hung, Jaw-Ching Wu, Chien-Wei Su, Shi-Ming Lin, Chun-Ying Wu, Yao-Chun Hsu, Chao-Wei Hsu, Yen-Hsuan Ni, Chien-Wei Su, Chien-Hung Chen, Cheng-Chung Wu, Shi-Ming Lin, Jen-I. Hwang, Chiun Hsu, Shang-Wen Chen, Chih-Lin Lin. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. Journal of the Formosan Medical Association 2018; 117(5): 381 doi: 10.1016/j.jfma.2017.09.007
|
| 131 |
Ming-Chih Chern, Vincent P. Chuang, Chung-Ting Liang, Z.H. Lin, Tse-Ming Kuo. Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma with Portal Vein Invasion: Safety, Efficacy, and Prognostic Factors. Journal of Vascular and Interventional Radiology 2014; 25(1): 32 doi: 10.1016/j.jvir.2013.10.013
|
| 132 |
Jian‐Jun Leng, Yin‐Zhe Xu, Jia‐Hong Dong. Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta‐analysis. ANZ Journal of Surgery 2016; 86(10): 816 doi: 10.1111/ans.12803
|
| 133 |
Rodrigo Canellas, Farhad Mehrkhani, Manuel Patino, Avinash Kambadakone, Dushyant Sahani. Characterization of Portal Vein Thrombosis (Neoplastic Versus Bland) on CT Images Using Software-Based Texture Analysis and Thrombus Density (Hounsfield Units). American Journal of Roentgenology 2016; 207(5): W81 doi: 10.2214/AJR.15.15928
|
| 134 |
Chae-June Lim, Ji-Yun Hong, Yang-Seok Ko, Min-Woo Chung, Chung-Hwan Jun, Sung-Kyu Choi, Sung-Bum Cho. High-dose versus Low-dose 5-Fluorouracil and Cisplatin Based Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma. Journal of Liver Cancer 2019; 19(1): 38 doi: 10.17998/jlc.19.1.38
|
| 135 |
Julien Edeline, Laurence Crouzet, Boris Campillo-Gimenez, Yan Rolland, Marc Pracht, Anne Guillygomarc’h, Karim Boudjema, Laurence Lenoir, Xavier Adhoute, Tanguy Rohou, Eveline Boucher, Bruno Clément, Jean-Frédéric Blanc, Etienne Garin. Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis. European Journal of Nuclear Medicine and Molecular Imaging 2016; 43(4): 635 doi: 10.1007/s00259-015-3210-7
|
| 136 |
Hidetoshi Nitta, Toru Beppu, Katsunori Imai, Hiromitsu Hayashi, Akira Chikamoto, Hideo Baba. Adjuvant Hepatic Arterial Infusion Chemotherapy after Hepatic Resection of Hepatocellular Carcinoma With Macroscopic Vascular Invasion. World Journal of Surgery 2013; 37(5): 1034 doi: 10.1007/s00268-013-1957-1
|
| 137 |
S. Heinrich, J. Baumgart, J. Mittler, H. Lang. Gefäßrekonstruktionen in der Leberchirurgie. Der Chirurg 2016; 87(2): 100 doi: 10.1007/s00104-015-0144-3
|
| 138 |
Wansheng Wang, Chen Wang, Jian Shen, Baosheng Ren, Yu Yin, Jun Yang, Haohuan Tang, Xiaoli Zhu, Caifang Ni. Integrated I-125 Seed Implantation Combined with Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombus. CardioVascular and Interventional Radiology 2021; 44(10): 1570 doi: 10.1007/s00270-021-02887-1
|
| 139 |
Ahmed Abo Gabal, Mohamed Lotayef, Hoda Abd Elbaky, Maha Hassan, Heba Elzawahry, Ekram Hamed. Management of Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Using Three-Dimensional Conformal Radiotherapy. Journal of Cancer Therapy 2017; 8(06): 579 doi: 10.4236/jct.2017.86049
|
| 140 |
Mariangela Malaguarnera, Vito Emanuele Catania, Antonio Maria Borzì, Stefano Malaguarnera, Roberto Madeddu, Gaetano Bertino, Saverio Latteri. Blood homocysteine levels are increased in hepatocellular carcinoma patients with portal vein thrombosis. A single centre retrospective cohort study. International Journal of Surgery Open 2018; 15: 60 doi: 10.1016/j.ijso.2018.11.001
|
| 141 |
Kuniaki Fukuda, Toshiyuki Okumura, Masato Abei, Nobuyoshi Fukumitsu, Kazunori Ishige, Masashi Mizumoto, Naoyuki Hasegawa, Haruko Numajiri, Kayoko Ohnishi, Hitoshi Ishikawa, Koji Tsuboi, Hideyuki Sakurai, Ichinosuke Hyodo. Long‐term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma. Cancer Science 2017; 108(3): 497 doi: 10.1111/cas.13145
|
| 142 |
Raffaella Tortora, Nunzia Farella, Filomena Morisco, Carmine Coppola, Francesco Izzo, Angelo Salomone Megna, Alessandro Federico, Vincenzo Messina, Gerardo Nardone, Guido Piai, Enrico Ragone, Luigi Elio Adinolfi, Giuseppe D’Adamo, Maria Stanzione, Giampiero Francica, Pietro Torre, Vincenzo De Girolamo, Nicola Coppola, Maria Guarino, Marcello Dallio, Lucia Rocco, Giovan Giuseppe Di Costanzo. Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2023; 35(7): 734 doi: 10.1097/MEG.0000000000002549
|
| 143 |
Xue‐Bin Zhang, Jian‐Hua Wang, Zhi‐Pin Yan, Sheng Qian, Shi‐Suo Du, Zhao‐Chong Zeng. Hepatocellular carcinoma with main portal vein tumor thrombus. Cancer 2009; 115(6): 1245 doi: 10.1002/cncr.24139
|
| 144 |
Axel Van Der Gucht, Mario Jreige, Alban Denys, Paul Blanc-Durand, Ariane Boubaker, Anastasia Pomoni, Periklis Mitsakis, Marina Silva-Monteiro, Silvano Gnesin, Marie Nicod Lalonde, Rafael Duran, John O. Prior, Niklaus Schaefer. Resin Versus Glass Microspheres for 90Y Transarterial Radioembolization: Comparing Survival in Unresectable Hepatocellular Carcinoma Using Pretreatment Partition Model Dosimetry. Journal of Nuclear Medicine 2017; 58(8): 1334 doi: 10.2967/jnumed.116.184713
|
| 145 |
Michinori Hamaoka, Tsuyoshi Kobayashi, Shintaro Kuroda, Hiroshi Iwako, Sho Okimoto, Tomoki Kimura, Hiroshi Aikata, Yasushi Nagata, Kazuaki Chayama, Hideki Ohdan. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study. International Journal of Surgery 2017; 44: 223 doi: 10.1016/j.ijsu.2017.06.082
|
| 146 |
Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis. Clinical and Molecular Hepatology 2016; 22(1): 160 doi: 10.3350/cmh.2016.22.1.160
|
| 147 |
Leandro Cardarelli-Leite, John Chung, Darren Klass, Vladimir Marquez, Frank Chou, Stephen Ho, Henry Walton, Howard Lim, Peter Tae Wan Kim, Anastasia Hadjivassiliou, David M. Liu. Ablative Transarterial Radioembolization Improves Survival in Patients with HCC and Portal Vein Tumor Thrombus. CardioVascular and Interventional Radiology 2020; 43(3): 411 doi: 10.1007/s00270-019-02404-5
|
| 148 |
Jing Chen, Chengya Zhou, Yu Long, Xude Yin. Sunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study. Tumor Biology 2015; 36(1): 183 doi: 10.1007/s13277-014-2608-3
|
| 149 |
Laura Prakash, Jeffrey E. Lee, James Yao, Priya Bhosale, Aparna Balachandran, Huamin Wang, Jason B. Fleming, Matthew H.G. Katz. Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors. Journal of Gastrointestinal Surgery 2015; 19(11): 2011 doi: 10.1007/s11605-015-2914-0
|
| 150 |
Xue-Bin Zhang, Jian-Hua Wang, Zhi-Ping Yan, Sheng Qian, Rong Liu. Hepatocellular Carcinoma Invading the Main Portal Vein: Treatment with Transcatheter Arterial Chemoembolization and Portal Vein Stenting. CardioVascular and Interventional Radiology 2009; 32(1): 52 doi: 10.1007/s00270-008-9454-x
|
| 151 |
Kichang Han, Jin Hyoung Kim, Gi-Young Ko, Dong Il Gwon, Kyu-Bo Sung. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review. World Journal of Gastroenterology 2016; 22(1): 407-416 doi: 10.3748/wjg.v22.i1.407
|
| 152 |
Pi-Yi Chang, Rheun-Chuan Lee, Po-Chin Liang, Yi-Sheng Liu, Vicent P. Chuang, Ding-Kwo Wu, Yu-Fan Cheng, Jen-I. Huang, Hsiuo-Shan Tseng, Chien-Fu Hung, Reng-Hong Wu, Ming-Chih Chern, Hua-Ming Cheng, Chih-Horng Wu, She-Meng Cheng, Chia-Ling Chiang, Huei-Lung Liang. Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1186674
|
| 153 |
Jie Shi, Eric C. H. Lai, Nan Li, Wei-Xing Guo, Jie Xue, Wan Yee Lau, Meng-Chao Wu, Shu-Qun Cheng. Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Annals of Surgical Oncology 2010; 17(8): 2073 doi: 10.1245/s10434-010-0940-4
|
| 154 |
Yi-Peng Fu, Yong Yi, Jin-Long Huang, Chu-Yu Jing, Jian Sun, Xiao-Chun Ni, Zhu-Feng Lu, Ya Cao, Jian Zhou, Jia Fan, Shuang-Jian Qiu. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection. The Oncologist 2017; 22(5): 561 doi: 10.1634/theoncologist.2016-0231
|
| 155 |
Yan Liu, Ruibao Liu, Ping Wang, Shijie Li, Haiyang Shen. Percutaneous implantation of 125iodine seeds for treatment of portal vein tumor thrombosis in hepatocellular carcinoma. Medical Oncology 2015; 32(8) doi: 10.1007/s12032-015-0657-0
|
| 156 |
JianJun Luo, ZhiPing Yan, QinXin Liu, XuDong Qu, JianHua Wang. Endovascular Placement of Iodine-125 Seed Strand and Stent Combined with Chemoembolization for Treatment of Hepatocellular Carcinoma with Tumor Thrombus in Main Portal Vein. Journal of Vascular and Interventional Radiology 2011; 22(4): 479 doi: 10.1016/j.jvir.2010.11.029
|
| 157 |
Chetana Lim, Philippe Compagnon, Mylène Sebagh, Chady Salloum, Julien Calderaro, Alain Luciani, Gérard Pascal, Alexis Laurent, Eric Levesque, Umberto Maggi, Cyrille Feray, Daniel Cherqui, Denis Castaing, Daniel Azoulay. Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery. HPB 2015; 17(7): 611 doi: 10.1111/hpb.12416
|
| 158 |
Zi-Han Zhang, Si-Nan Hou, Jia-Ze Yu, Wen Zhang, Jing-Qin Ma, Min-Jie Yang, Qing-Xin Liu, Ling-Xiao Liu, Jian-Jun Luo, Xu-Dong Qu, Zhi-Ping Yan. Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1086095
|
| 159 |
Toshihiro Kawai, Takafumi Sugimoto, Yuji Kondo, Miho Kanda, Shinpei Sato, Shuntaro Obi. A case of a super-elderly patient with advanced hepatocellular carcinoma and portal vein invasion successfully treated with hepatic arterial infusion chemotherapy. Kanzo 2018; 59(10): 545 doi: 10.2957/kanzo.59.545
|
| 160 |
Michitoshi Takano, Takashi Kokudo, Yoshihiro Miyazaki, Yumiko Kageyama, Amane Takahashi, Katsumi Amikura, Hirohiko Sakamoto. Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(42): 9445-9450 doi: 10.3748/wjg.v22.i42.9445
|
| 161 |
Xiao-Jie Lu, Jing Dong, Li-Juan Ji, Li-Xin Xiao, Chang-Quan Ling, Jun Zhou. Tolerability and efficacy of gamma knife radiosurgery on hepatocellular carcinoma with portal vein tumor thrombosis. Oncotarget 2016; 7(3): 3614 doi: 10.18632/oncotarget.6118
|
| 162 |
Masahiro Murakami, Shogo Kobayashi, Shigeru Marubashi, Yoshito Tomimaru, Takehiro Noda, Hiroshi Wada, Hidetoshi Eguchi, Yutaka Takeda, Masahiro Tanemura, Koji Umeshita, Yuichiro Doki, Masaki Mori, Hiroaki Nagano. Tyrosine Kinase Inhibitor PTK/ZK Enhances the Antitumor Effects of Interferon-α/5-Fluorouracil Therapy for Hepatocellular Carcinoma Cells. Annals of Surgical Oncology 2011; 18(2): 589 doi: 10.1245/s10434-010-1310-y
|
| 163 |
Chuanming Li, Jiani Hu, Daiquan Zhou, Jun Zhao, Kuansheng Ma, Xuntao Yin, Jian Wang. Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-590
|
| 164 |
Tao Sun, Lei Chen, Xuefeng Kan, Yanqiao Ren, Yanyan Cao, Weihua Zhang, Haohao Lu, Chuansheng Zheng, San Lin You. A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/1255133
|
| 165 |
Emily L. Ryon, Joshua P. Kronenfeld, Rachel M. Lee, Adam Yopp, Annie Wang, Ann Y. Lee, Sommer Luu, Cary Hsu, Eric Silberfein, Maria C. Russell, Neha Goel, Nipun B. Merchant, Jashodeep Datta. Surgical management of hepatocellular carcinoma patients with portal vein thrombosis: The United States Safety Net and Academic Center Collaborative Analysis. Journal of Surgical Oncology 2021; 123(2): 407 doi: 10.1002/jso.26282
|
| 166 |
Takashi Kokudo, Kiyoshi Hasegawa, Yutaka Matsuyama, Tadatoshi Takayama, Namiki Izumi, Masumi Kadoya, Masatoshi Kudo, Shoji Kubo, Michiie Sakamoto, Osamu Nakashima, Takashi Kumada, Norihiro Kokudo. Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey. Hepatology 2017; 66(2): 510 doi: 10.1002/hep.29225
|
| 167 |
Beom-Hui Lee, Dong-Shik Lee, Chan Woo Cho, Sung-Su Yun. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1685-6
|
| 168 |
Shi-Qiang Shen, Kun Li, Neng Zhu, Akimasa Nakao. Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma. Medical Oncology 2008; 25(3): 341 doi: 10.1007/s12032-008-9042-6
|
| 169 |
John Mutai, Twahirwa Nebayosi, Joyce Sande, M. V. Shah. Isolated Portal Venous Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2017; 48(1): 80 doi: 10.1007/s12029-016-9805-9
|
| 170 |
Jian-Hai Guo, Shao-Xing Liu, Song Gao, Fu-Xin Kou, Xin Zhang, Di Wu, Xiao-Ting Li, Hui Chen, Xiao-Dong Wang, Peng Liu, Peng-Jun Zhang, Hai-Feng Xu, Guang Cao, Lin-Zhong Zhu, Ren-Jie Yang, Xu Zhu. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(27): 3971 doi: 10.3748/wjg.v26.i27.3971
|
| 171 |
Chong De Lu, Kang Wang, Cun Zhen Zhang, Fei Guo Zhou, Wei Xing Guo, Meng Chao Wu, Shu Qun Cheng. Outcomes of intrahepatic cholangiocarcinoma with portal vein tumor thrombus following hepatic resection. Journal of Gastroenterology and Hepatology 2016; 31(7): 1330 doi: 10.1111/jgh.13309
|
| 172 |
Qiuyan Lin, Xiaoquan Huang, Canmei Zhong, Tiancheng Luo, Xiaoqing Zeng, Shiyao Chen. Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity‐matched analysis of Surveillance, Epidemiology, and End Results database. Cancer Medicine 2019; 8(2): 515 doi: 10.1002/cam4.1937
|
| 173 |
Fabian Stoehr, Roman Kloeckner, Daniel Pinto dos Santos, Mira Schnier, Lukas Müller, Aline Mähringer-Kunz, Thomas Dratsch, Sebastian Schotten, Arndt Weinmann, Peter Robert Galle, Jens Mittler, Christoph Düber, Felix Hahn. Radiomics-Based Prediction of Future Portal Vein Tumor Infiltration in Patients with HCC—A Proof-of-Concept Study. Cancers 2022; 14(24): 6036 doi: 10.3390/cancers14246036
|
| 174 |
Xiao Xu, Xuyong Wei, Qi Ling, Jun Cheng, Bin Zhou, Haiyang Xie, Lin Zhou, Shusen Zheng. Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: Protein disulfide‐isomerase A6 and apolipoprotein A‐I. Journal of Gastroenterology and Hepatology 2011; 26(12): 1787 doi: 10.1111/j.1440-1746.2011.06796.x
|
| 175 |
Ahmed Shehta, Ahmed M. Elsabbagh, Mohamed Medhat, Ahmed Farouk, Ahmed Monier, Rami Said, Tarek Salah, Mohamed Elshobari, Amgad Fouad, Ahmed N. Elghawalby. Impact of tumor size on the outcomes of hepatic resection for hepatocellular carcinoma: a retrospective study. BMC Surgery 2024; 24(1) doi: 10.1186/s12893-023-02296-w
|
| 176 |
Jong Ryul Eun, Heon Ju Lee, Hee Jung Moon, Tae Nyeun Kim, Jae Woon Kim, Jay Chun Chang. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-α for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis. Scandinavian Journal of Gastroenterology 2009; 44(12): 1477 doi: 10.3109/00365520903367262
|
| 177 |
Changfu Liu, Wenge Xing, Tongguo Si, Haipeng Yu, Zhi Guo. Efficacy and safety of apatinib combined with transarterial chemoembolization for hepatocellular carcinoma with portal venous tumor thrombus: a retrospective study. Oncotarget 2017; 8(59): 100734 doi: 10.18632/oncotarget.20140
|
| 178 |
Yong-Fa Zhang, Rong-Ping Guo, Ru-Hai Zou, Jing-Xian Shen, Wei Wei, Shao-Hua Li, Han-Yue OuYang, Hong-Bo Zhu, Li Xu, Xiang-Ming Lao, Ming Shi. Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study. European Radiology 2016; 26(7): 2078 doi: 10.1007/s00330-015-4021-8
|
| 179 |
Lucia Cerrito, Brigida Eleonora Annicchiarico, Roberto Iezzi, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers. World Journal of Gastroenterology 2019; 25(31): 4360-4382 doi: 10.3748/wjg.v25.i31.4360
|
| 180 |
Yin Cao, WenWen Ding, JingZi Zhang, Qi Gao, HaoXiang Yang, WangSen Cao, ZhongXia Wang, Lei Fang, RongHui Du. Significant Down-Regulation of Urea Cycle Generates Clinically Relevant Proteomic Signature in Hepatocellular Carcinoma Patients with Macrovascular Invasion. Journal of Proteome Research 2019; 18(5): 2032 doi: 10.1021/acs.jproteome.8b00921
|
| 181 |
Shu-Bin Zhang, Zi-Xuan Hu, Zhong-Qiang Xing, Ang Li, Xin-Bo Zhou, Jian-Hua Liu. Portal vein thrombosis in a noncirrhotic patient after hemihepatectomy: A case report and review of literature. World Journal of Clinical Cases 2022; 10(20): 7130-7137 doi: 10.12998/wjcc.v10.i20.7130
|
| 182 |
Jin‐Cheng Wang, An‐Liang Xia, Yong Xu, Xiao‐Jie Lu. Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis. Journal of Cellular Physiology 2019; 234(2): 1062 doi: 10.1002/jcp.27324
|
| 183 |
Atsushi Nanashima, Syuuichi Tobinaga, Takafumi Abo, Masaki Kunizaki, Hiroaki Takeshita, Shigekazu Hidaka, Naota Taura, Tatsuki Ichikawa, Terumitsu Sawai, Kazuhiko Nakao, Takeshi Nagayasu. Usefulness of sonazoid–ultrasonography during hepatectomy in patients with liver tumors: A preliminary study. Journal of Surgical Oncology 2011; 103(2): 152 doi: 10.1002/jso.21782
|
| 184 |
Yixin Ding, Shasha Wang, Zhenkang Qiu, Chunyang Zhu, Yan Wang, Shufen Zhao, Wensheng Qiu, Kongjia Wang, Jing Lv, Weiwei Qi. The worthy role of hepatic arterial infusion chemotherapy in combination with anti-programmed cell death protein 1 monoclonal antibody immunotherapy in advanced hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1284937
|
| 185 |
Arvinder Soin, Mickaël Lesurtel, Prashant Bhangui, Lorenzo Cocchi, Mohamed Bouattour, Pierre-Alain Clavien. Are patients with hepatocellular carcinoma and portal vein tumour thrombosis candidates for liver transplantation?. Journal of Hepatology 2023; 78(6): 1124 doi: 10.1016/j.jhep.2023.03.032
|
| 186 |
Goh Eun Chung, Jeong-Hoon Lee, Hwi Young Kim, Sang Youn Hwang, Joon Suk Kim, Jin Wook Chung, Jung-Hwan Yoon, Hyo-Suk Lee, Yoon Jun Kim. Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall Survival. Radiology 2011; 258(2): 627 doi: 10.1148/radiol.10101058
|
| 187 |
Nan Li, Bin Chen, Run Lin, Ni Liu, Hai-tao Dai, Ke-yu Tang, Jian-yong Yang, Yong-hui Huang. The earlier, the better: the effects of different administration timepoints of sorafenib in suppressing the carcinogenesis of VEGF in rats. Cancer Chemotherapy and Pharmacology 2018; 81(1): 207 doi: 10.1007/s00280-017-3493-4
|
| 188 |
Arvinder S. Soin, Prashant Bhangui, Tejinder Kataria, Sanjay S. Baijal, Tarun Piplani, Dheeraj Gautam, Narendra S. Choudhary, Srinivasan Thiagarajan, Amit Rastogi, Neeraj Saraf, Sanjiv Saigal. Experience With LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging. Transplantation 2020; 104(11): 2334 doi: 10.1097/TP.0000000000003162
|
| 189 |
Junfei Jin, Pengpeng Zhu, Yan Liao, Jun Li, Weijia Liao, Songqing He. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection. Oncotarget 2015; 6(22): 19217 doi: 10.18632/oncotarget.4265
|
| 190 |
Guanheng Wu, Guomin Huang, Jianwen Huang, Ligong Lu, Shaojun Peng, Yong Li, Wei Zhao. Comparison of External Beam Radiation Therapy Modalities for Hepatocellular Carcinoma With Macrovascular Invasion: A Meta-Analysis and Systematic Review. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.829708
|
| 191 |
Yong-Fa Zhang, Yong Le, Wei Wei, Ru-Hai Zou, Jia-Hong Wang, Han-Yue OuYang, Cheng-Zuo Xiao, Xiao-Ping Zhong, Ming Shi, Rong-Ping Guo. Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis. Oncotarget 2016; 7(25): 38845 doi: 10.18632/oncotarget.8642
|
| 192 |
Luciano Tarantino, Giuseppina Busto, Aurelio Nasto, Raffaele Fristachi, Luigi Cacace, Maria Talamo, Catello Accardo, Sara Bortone, Paolo Gallo, Paolo Tarantino, Riccardo Aurelio Nasto, Matteo Nicola Dario Di Minno, Pasquale Ambrosino. Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study. World Journal of Gastroenterology 2017; 23(5): 906-918 doi: 10.3748/wjg.v23.i5.906
|
| 193 |
Lin-Zhong Zhu, Song Xu, Hai-Long Qian. Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus. World Journal of Gastroenterology 2018; 24(23): 2501-2507 doi: 10.3748/wjg.v24.i23.2501
|
| 194 |
Jian Lu, Jin-He Guo, Hai-Dong Zhu, Guang-Yu Zhu, Li Chen, Gao-Jun Teng. Safety and Efficacy of Irradiation Stent Placement for Malignant Portal Vein Thrombus Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience. Journal of Vascular and Interventional Radiology 2017; 28(6): 786 doi: 10.1016/j.jvir.2017.02.014
|
| 195 |
Vaneet Jearth, Prachi S Patil, Shaesta Mehta, Mahesh Goel, Shraddha Patkar, Suyash Kulkarni, Nitin Shetty, Vikas Ostwal, Anant Ramaswamy, Supriya Sastri, Reena Engineer. A study of the clinical profile, predictors, prognostic features, and survival of patients with hepatocellular carcinoma having macroscopic portal vein tumor thrombosis. Indian Journal of Gastroenterology 2022; 41(6): 533 doi: 10.1007/s12664-022-01289-6
|
| 196 |
Jie Tian, Jingwei Wei, Sirui Fu, Shauitong Zhang, Jie Zhang, Dongsheng Gu, Ligong Lu, Xiaoqun Li, Xudong Chen, Xiaofeng He, Jianfeng Yan, Horst K. Hahn, Kensaku Mori. Development and validation of a radiomics-based method for macrovascular invasion prediction in hepatocellular carcinoma with prognostic implication. Medical Imaging 2019: Computer-Aided Diagnosis 2019; : 59 doi: 10.1117/12.2510932
|
| 197 |
Liang Zhang, Jun Wang, Yang Li, Leina Hou, Jianguo Xia, Jialin Shen. Implanting Iodine-125 Seed Strand Inside the Portal Vein Stent: An Improved Approach to Endovascular Brachytherapy for Treatment of Patients with Hepatocellular Carcinoma and Main Portal Vein Tumor Thrombus. Journal of Hepatocellular Carcinoma 2023; : 2187 doi: 10.2147/JHC.S430686
|
| 198 |
Wenchang Yu, Weifu Liu, Kongzhi Zhang, Shiguang Chen, Xiaolong Wang. Transarterial interventional therapy combined with tyrosine kinase inhibitors with or without anti-PD-1 antibodies as initial treatment for hepatocellular carcinoma with major portal vein tumor thrombosis: a single-center retrospective study. Cancer Immunology, Immunotherapy 2023; 72(11): 3609 doi: 10.1007/s00262-023-03511-6
|
| 199 |
Charles E. Woodall, Charles R. Scoggins, Susan F. Ellis, Clifton M. Tatum, Michael J. Hahl, Kadiyala V. Ravindra, Kelly M. McMasters, Robert C.G. Martin. Is Selective Internal Radioembolization Safe and Effective for Patients with Inoperable Hepatocellular Carcinoma and Venous Thrombosis?. Journal of the American College of Surgeons 2009; 208(3): 375 doi: 10.1016/j.jamcollsurg.2008.12.009
|
| 200 |
Hideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, Kazuomi Ueshima, Joji Tani, Teiji Kuzuya, Kazuhiro Kasai, Youhei Kooka, Atsushi Hiraoka, Rie Sugimoto, Takehiro Yonezawa, Satoshi Tanaka, Akihiro Deguchi, Shigeo Shimose, Tomotake Shirono, Miwa Sakai, Hiroyuki Suzuki, Etsuko Moriyama, Hironori Koga, Takuji Torimura, Takumi Kawaguchi. The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function. Cancers 2022; 14(19): 4873 doi: 10.3390/cancers14194873
|
| 201 |
Marc Engelbrecht, Oguz Akin, Devesh Dixit, Lawrence Schwartz. Bland and tumor thrombi in abdominal malignancies: magnetic resonance imaging assessment in a large oncologic patient population. Abdominal Imaging 2011; 36(1): 62 doi: 10.1007/s00261-010-9608-6
|
| 202 |
Ming-Yang Chen, Yu-Chao Wang, Tsung-Han Wu, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Ngan-Ming Tsang, Kun-Ming Chan, Wei-Chen Lee. Efficacy of External Beam Radiation-Based Treatment plus Locoregional Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/6017406
|
| 203 |
Che-Yu Hsu, Chun-Wei Wang, Ann-Lii Cheng, Sung-Hsin Kuo. Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness. World Journal of Gastrointestinal Oncology 2019; 11(8): 579-588 doi: 10.4251/wjgo.v11.i8.579
|
| 204 |
Zheng-Hua Lu, Feng Shen, Zhen-Lin Yan, Jun Li, Jia-He Yang, Ming Zong, Le-Hua Shi, Meng-Chao Wu. Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation. Journal of Cancer Research and Clinical Oncology 2009; 135(6): 783 doi: 10.1007/s00432-008-0513-0
|
| 205 |
Yuna Kim, Han Ah Lee, Jae Seung Lee, Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Soon Ho Um, Yeon Seok Seo, Seung Up Kim. Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma. Cancer Investigation 2021; 39(3): 274 doi: 10.1080/07357907.2020.1870126
|
| 206 |
Qingling Hua, Dejun Zhang, Yunqiao Li, Yue Hu, Pian Liu, Guangqin Xiao, Tao Zhang, Jun Xue. Prognostic Factors of Survival of Advanced Liver Cancer Patients Treated With Palliative Radiotherapy: A Retrospective Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.658152
|
| 207 |
Duo Hong, Yi Zhou, Xiaoting Wan, Hongying Su, Haibo Shao. Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08680-0
|
| 208 |
Kazuhiro Kondo, Kazuo Chijiiwa, Masahiro Kai, Kazuhiro Otani, Koki Nagaike, Jiro Ohuchida, Masahide Hiyoshi, Motoaki Nagano. Surgical Strategy for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Based on Prognostic Factors. Journal of Gastrointestinal Surgery 2009; 13(6): 1078 doi: 10.1007/s11605-009-0854-2
|